Low-value Care

Use of term ‘low value’ may leave Black, Latinx patients with questions about access to care

Abstract: This is the second of two articles on reframing the debate about low-benefit treatments.

Publication: Association of Health Care Journalists

Date Published: August 20, 2021

Author(s): Kerry Dooley Young

View This Resource

Headlines

View our curated list of news articles about Low-value Care

Also on this site

  • Low-value services: Complications, variability, and measurement
  • Eliminating Medication Overload: A National Action Plan
    To eliminate medication overload, serious cultural, educational, and policy changes are needed. This action plan offers recommendations for policymakers, health care institutions, clinicians, and patients across five key categories to reduce harm from multiple medication use. Suggested Citation: Eliminating medication overload: A national action plan. Working Group on Medication Overload. Brookline, MA: The Lown Institute, 2020. DOI: https://doi.org/10.46241/LI.YLBW4885
  • Medication Overload: Reduce Pharmaceutical Industry Influence
    Pharmaceutical marketing is a significant factor in the growing public health crisis of medication overload, which puts millions of older adults at risk of preventable harm and premature death. This issue brief provides recommendations to reduce pharmaceutical industry influence by limiting pharma sales rep visits to clinicians and direct-to-consumer advertising.
  • Medication Overload: Improve Information at the Point of Care
    This issue brief provides recommendations for clinical practice guidelines and electronic health records that would give clinicians the information they need to appropriately prescribe and deprescribe.
  • Medication Overload: Educate and Train Health Professionals
    This issue brief recommends training health professionals to reduce medication overload, by incorporating information on geriatric care and deprescribing training into professional schools and continuing education.